Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion

[ad_1] Updated Dec. 26, 2023 12:33 pm ET Drug company Bristol-Myers Squibb struck a $4.1 billion deal to buy RayzeBio, in a bet on a re-emerging cancer drug technology.  RayzeBio…

AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion

[ad_1] AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business. The upfront cash…

Investigators Probe Whether U.S. Was Billed Twice for Coronavirus Research in China

[ad_1] Dec. 23, 2023 10:00 am ET WASHINGTON—Two federal inspectors general are investigating whether a nonprofit group involved in high-risk coronavirus research in China double-billed U.S. taxpayers for hundreds of…

Illumina to Divest Itself of Cancer-Test Maker Grail

[ad_1] Updated Dec. 17, 2023 8:16 pm ET Gene-sequencing company Illumina said Sunday it will divest itself of cancer blood test maker Grail, following Illumina’s loss in its legal battle…

Matthew Perry’s Death Darkens Ketamine’s Startup Glow

[ad_1] By Rolfe Winkler and Brianna Abbott Dec. 16, 2023 9:00 pm ET Matthew Perry’s death from the effects of ketamine brought new scrutiny to the booming business to prescribe…

Matthew Perry Died From Effects of Ketamine, Autopsy Shows

[ad_1] Updated Dec. 15, 2023 7:18 pm ET Matthew Perry died from the acute effects of ketamine, according to an autopsy of the “Friends” actor released Friday. The 54-year-old actor,…

Pfizer Warns 2024 Revenue Could Fall, Weighed Down by Soft Demand for Covid Products

[ad_1] Updated Dec. 13, 2023 10:16 am ET Pfizer shares tumbled Wednesday morning after the company said revenue could fall next year and issued 2024 guidance below analyst expectations. Shares…

The Forgotten Man of mRNA Research

[ad_1] Jason Schrum’s work helped lay the foundation for Moderna’s mRNA Covid vaccine, but he hasn’t won any prizes or royalties and left the company after disagreements. [ad_2] Source link

$19 Billion in a Week: AbbVie Makes Two Big Bets

[ad_1] Early last week, AbbVie was on every healthcare investment banker’s list. But with two quick deal announcements under its belt in just six days, AbbVie may have transformed its…

Covid-19 Cases Are Rising Again, Just in Time for the Holidays

[ad_1] In what is becoming a holiday-season tradition, Covid-19 cases are rising once again in the U.S., according to the Centers for Disease Control and Prevention. Doctors and virus trackers…